Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 75

1.

Residential addiction treatment for injection drug users requiring intravenous antibiotics: a cost-reduction strategy.

Jewell C, Weaver M, Sgroi C, Anderson K, Sayeed Z.

J Addict Med. 2013 Jul-Aug;7(4):271-6. doi: 10.1097/ADM.0b013e318294b1eb.

PMID:
23648642
2.

Home intravenous antibiotics in a tertiary care hospital in Saudi Arabia.

Baharoon S, Almodaimeg H, Al Watban H, Al Jahdali H, Alenazi T, Al Sayyari A, Al Dawood A, Al-Sultan M, Al Safi E.

Ann Saudi Med. 2011 Sep-Oct;31(5):457-61. doi: 10.4103/0256-4947.84621.

3.

Treatment of urinary tract infections among febrile young children with daily intravenous antibiotic therapy at a day treatment center.

Gauthier M, Chevalier I, Sterescu A, Bergeron S, Brunet S, Taddeo D.

Pediatrics. 2004 Oct;114(4):e469-76.

PMID:
15466073
4.

Residential rehabilitation for drug users: a review of 13 months' intake to a therapeutic community.

Keen J, Oliver P, Rowse G, Mathers N.

Fam Pract. 2001 Oct;18(5):545-8.

PMID:
11604381
5.
6.

Costs of day hospital and community residential chemical dependency treatment.

Kaskutas LA, Zavala SK, Parthasarathy S, Witbrodt J.

J Ment Health Policy Econ. 2008 Mar;11(1):27-32.

7.

Impact of a multidisciplinary approach on antibiotic consumption, cost and microbial resistance in a Czech hospital.

Mach R, Vlcek J, Prusova M, Batka P, Rysavy V, Kubena A.

Pharm World Sci. 2007 Oct;29(5):565-72.

PMID:
17610145
8.

[Linezolid in the treatment of antibiotic-resistant gram-positive infections of the musculoskeletal system].

Jahoda D, Nyc O, Pokorný D, Landor I, Sosna A.

Acta Chir Orthop Traumatol Cech. 2006 Oct;73(5):329-33. Czech.

PMID:
17140514
9.

Hospital utilization and costs in a cohort of injection drug users.

Palepu A, Tyndall MW, Leon H, Muller J, O'Shaughnessy MV, Schechter MT, Anis AH.

CMAJ. 2001 Aug 21;165(4):415-20.

10.

Appropriateness of antibiotic treatment in intravenous drug users, a retrospective analysis.

Mertz D, Viktorin N, Wolbers M, Laifer G, Leimenstoll B, Fluckiger U, Battegay M.

BMC Infect Dis. 2008 Apr 3;8:42. doi: 10.1186/1471-2334-8-42.

11.

Home intravenous antibiotic therapy. A safe and effective alternative to inpatient care.

Grayson ML, Silvers J, Turnidge J.

Med J Aust. 1995 Mar 6;162(5):249-53.

PMID:
7891605
12.

Primary pyogenic infection of the spine in intravenous drug users: a prospective observational study.

Wang Z, Lenehan B, Itshayek E, Boyd M, Dvorak M, Fisher C, Kwon B, Paquette S, Street J.

Spine (Phila Pa 1976). 2012 Apr 15;37(8):685-92. doi: 10.1097/BRS.0b013e31823b01b8.

PMID:
22037525
13.

Importance of nondrug costs of intravenous antibiotic therapy.

van Zanten AR, Engelfriet PM, van Dillen K, van Veen M, Nuijten MJ, Polderman KH.

Crit Care. 2003 Dec;7(6):R184-90.

14.

Cost and cost-effectiveness of hospital vs residential crisis care for patients who have serious mental illness.

Fenton WS, Hoch JS, Herrell JM, Mosher L, Dixon L.

Arch Gen Psychiatry. 2002 Apr;59(4):357-64.

PMID:
11926936
15.

A Cost Analysis of Hospitalizations for Infections Related to Injection Drug Use at a County Safety-Net Hospital in Miami, Florida.

Tookes H, Diaz C, Li H, Khalid R, Doblecki-Lewis S.

PLoS One. 2015 Jun 15;10(6):e0129360. doi: 10.1371/journal.pone.0129360.

16.

Needles and the damage done: reasons for admission and financial costs associated with injecting drug use in a Central London Teaching Hospital.

Marks M, Pollock E, Armstrong M, Morris-Jones S, Kidd M, Gothard P, Noursadeghi M, Doherty JF.

J Infect. 2013 Jan;66(1):95-102. doi: 10.1016/j.jinf.2012.10.004.

PMID:
23068454
17.

Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach.

Birkhead GS, Klein SJ, Candelas AR, O'Connell DA, Rothman JR, Feldman IS, Tsui DS, Cotroneo RA, Flanigan CA.

Int J Drug Policy. 2007 Oct;18(5):417-25. Review.

PMID:
17854731
18.

Outcomes of an antimicrobial control program in a teaching hospital.

Gentry CA, Greenfield RA, Slater LN, Wack M, Huycke MM.

Am J Health Syst Pharm. 2000 Feb 1;57(3):268-74.

PMID:
10674779
20.

Cost of care for inpatients with community-acquired intra-abdominal infections.

Cattan P, Yin DD, Sarfati E, Lyu R, De Zelicourt M, Fagnani F.

Eur J Clin Microbiol Infect Dis. 2002 Nov;21(11):787-93.

PMID:
12461588

Supplemental Content

Support Center